Accessibility Menu

Terumo(FRA) TUO

Market Cap€20.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€13.39
-0.48%
-0.06Today

Terumo Financials at a Glance

Market Cap

€20.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€6.57K

Net Income (TTM)

€909.28

EPS (TTM)

€0.62

P/E Ratio

22.02

Dividend

€0.17

Beta (Volatility)

0.07 (Low)

Price

€13.39

Volume

0

Open

€13.39

Previous Close

€13.39

Daily Range

€13.39 - €13.39

52-Week Range

€10.15 - €15.50

Estimated Earnings Date

N/A

TUO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Terumo

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.

Industry

Healthcare Equipment and Supplies

Employees

31,185

CEO

Hikaru Samejima, MBA

TUO Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

10.69%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.54%

Dividend Yield

1.24%

Payout Ratio

N/A

Stock Overview

Market Cap

€20.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.48B

Volume

0

Avg. Volume

34.546

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Terumo Performance Analysis

Terumo annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31EUR 5,820,729,0948.0%
20242024-03-31EUR 5,887,481,4091.1%
20252025-03-31EUR 6,331,074,3297.5%
20262026-03-31EUR 6,482,301,0622.4%
Terumo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31EUR 0.42-6.1%
20242024-03-31EUR 0.468.1%
20252025-03-31EUR 0.485.7%
20262026-03-31EUR 0.539.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€1.68K

+1.1%

Gross Profit

€963.61

+1.1%

Gross Margin

57.26%

+1.0%

Market Cap

€20.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.56

N/A

Employees

31,185

N/A

Net Income

€380.10

+1.5%

EBITDA

€518.29

+1.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€3.79K

+71.7%

Total Debt

€2.10K

+2.1%

Accounts Receivable

€1.20K

+1.1%

Inventory

€1.84K

+1.0%

Long Term Debt

€1.13K

+1.9%

Short Term Debt

€968.39

+2.3%

Return on Assets

7.78%

+1.1%

Return on Invested Capital

7.49%

+1.0%

Free Cash Flow

€333.92

+3.5%

Operating Cash Flow

€401.97

+2.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About TUO

What is the current price of Terumo?

Terumo is trading at €13.39 per share.

What is the 52-week range for Terumo?

Over the past 52 weeks, Terumo has traded between €10.15 and €15.50.

How much debt does Terumo have?

As of the most recent reporting period, Terumo reported total debt of €2.10B.

How much cash does Terumo have on hand?

Terumo reported €1.69B in cash and cash equivalents in its most recent financial results.

What is Terumo’s dividend yield?

Terumo currently has a dividend yield of 1.24%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.